Phenotypic change of macrophages in lung tissue during the development of hepatopulmonary syndrome

Li Xujiong, Zhang Huiying, Chen Yunxia, Tian Xiaoxia, Lai Lina

Chinese Journal of Clinical Anatomy ›› 2022, Vol. 40 ›› Issue (1) : 44-48.

PDF(6652 KB)
PDF(6652 KB)
Chinese Journal of Clinical Anatomy ›› 2022, Vol. 40 ›› Issue (1) : 44-48. DOI: 10.13418/j.issn.1001-165x.2022.1.09

Phenotypic change of macrophages in lung tissue during the development of hepatopulmonary syndrome

  • Li Xujiong1, Zhang Huiying2*, Chen Yunxia3, Tian Xiaoxia2, Lai Lina4
Author information +
History +

Abstract

Objective To investigate the phenotypic change of macrophages in lung tissue during the development of hepatopulmonary syndrome (HPS). Methods The HPS model was induced by multiple pathogenic factors in Sprague-Dawley rats and divided into HPS groups of the 4th week,the 6th week and the 8th week. Normal control groups at the corresponding time points were also set up. Liver and Lung tissue histology was observed by HE staining. VG staining method was used to observe the liver fibrosis. Immunofluorescence method was used to observe the macrophage marker (CD68). The expressions of M1/M2 macrophage markers (CD86 and CD206) were detected by real-time PCR assay, while the expressions of corresponding secretions iNOS, TNF-α, Arg-1 and IL10 were detected by Elisa. Results With the progress of the disease, the expression of CD86, iNOS and TNF-α gradually increased in the lung tissue of model group. After reaching the peak in the 6th weeks, CD86 and iNOS fell back. While the expression of CD206, Arg-1 and IL10 began to increase significantly at the 6th week. There was a positive correlation between iNOS and CD86 in the lung tissue of the model group. Arg-1 was positively correlated with CD206. IL10 was positively correlated with CD206. Conclusions During the pathogenesis of HPS, macrophages in lung tissue underwent a series of phenotypic changes, with M1 predominating at 6 weeks and M2 predominating at 8 weeks.   

Key words

Hepatopulmonary syndrome /  Macrophages /  M1 /  M2

Cite this article

Download Citations
Li Xujiong, Zhang Huiying, Chen Yunxia, Tian Xiaoxia, Lai Lina. Phenotypic change of macrophages in lung tissue during the development of hepatopulmonary syndrome[J]. Chinese Journal of Clinical Anatomy. 2022, 40(1): 44-48 https://doi.org/10.13418/j.issn.1001-165x.2022.1.09

References

[1]  Arora S, Dev K, Agarwal B, et al. Macrophages: their role, activation and polarization in pulmonary diseases[J]. Immunobiology, 2018, 223(4-5): 383-396. DOI: 10.1016/j.imbio.2017.11.001.
[2]  Zhang HY, Han DW, Zhao ZF, et al. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia[J]. World J Gastroenterol, 2007, 13(25): 3500-3507. DOI: 10.3748/wjg.v13.i25.3500.
[3]  Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines[J]. Immunity, 2014, 41(1): 14-20. DOI: 10.1016/j.immuni.2014.06.008.
[4]  Wang N, Liang HW, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance[J]. Front Immunol, 2014, 5: 614. DOI: 10.3389/fimmu.2014.00614.
[5] Rőszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms[J]. Mediators Inflamm, 2015, 2015: 816460. DOI: 10.1155/2015/816460.
[6] Abdelaziz MH, Abdelwahab SF, Wan J, et al. Alternatively activated macrophages; a double-edged sword in allergic asthma[J]. J Transl Med, 2020, 18(1): 58. DOI: doi: 10.1186/s12967-020-02251-w.
[7] Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9): 6425-6440. DOI: 10.1002/jcp.26429.
[8]  D da Silva M, Bobinski F, Sato KL, et al. IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain[J]. Mol Neurobiol, 2015, 51(1): 19-31. DOI: 10.1007/s12035-014-8790-x.
[9] Bi Y, Chen J, Hu F, et al. M2 macrophages as a potential target for antiatherosclerosis treatment[J]. Neural Plast, 2019, 2019: 6724903. DOI: 10.1155/2019/6724903.

PDF(6652 KB)

Accesses

Citation

Detail

Sections
Recommended

/